Keyphrases
Melanocytic Lesions
82%
N-(2-hydroxypropyl)methacrylamide Copolymers
72%
Cancer Stem Cells
71%
HPMA Copolymers
61%
Melanoma
55%
Prostate Cancer
51%
Molecular Characterization
41%
Gene Expression Profile
41%
Anticancer Nanomedicine
41%
Combination Therapy
41%
Degradable
41%
Gemcitabine
41%
Cyclopamine
35%
Drug Conjugates
34%
Targeted Therapy
34%
Inhibitory Effect
33%
Spitz Tumor
30%
Nevus
30%
Cytotoxicity
30%
Stem Progenitor Cells
29%
Metastasis
27%
Metastatic Melanoma
27%
Malignant Melanoma
27%
Ovarian Cancer
27%
GDC-0980
26%
Docetaxel
24%
Tumor Cells
22%
Malignancy
22%
Tumor
22%
Glucocorticoid Drugs
20%
SOX17
20%
PRAME
20%
Differential Expression
20%
Accuracy Management
20%
Spitz Neoplasm
20%
Testicular Germ Cell Tumor
20%
Patient Management
20%
Young Age
20%
Late-onset
20%
Disease Classification
20%
Genetic Characterization
20%
Recent Advances
20%
Disease Diagnosis
20%
Cell Morphology
20%
Process Pattern
20%
Therapeutic Efficacy
20%
Acute Cellular Rejection
20%
Diagnostic Accuracy
20%
Prednisolone
20%
Therapeutic Safety
20%
Medicine and Dentistry
Melanoma
100%
Neoplasm
63%
Nevus
43%
Gene Expression
41%
Copolymer
41%
Targeted Therapy
34%
Metastatic Carcinoma
34%
Biopsy Technique
32%
Cancer
31%
Spitz Nevus
30%
Disease
24%
Cancer Cell
24%
Malignant Neoplasm
24%
Diagnosis
22%
Carcinoma Cell
22%
Germinoma
20%
Kidney Tumour
20%
Tumor Seeding
20%
Tumor Biopsy
20%
Nosology
20%
Cutaneous Melanoma
20%
Allograft
20%
Acute Graft Rejection
20%
Spine
20%
Cytotoxicity
20%
Gemcitabine
20%
Krukenberg Tumor
20%
Prostate Cancer
20%
Combination Therapy
20%
Progenitor Cell
20%
Metastatic Melanoma
19%
Tumor Progression
17%
Seminoma
16%
Immunohistochemistry
13%
Protein Tyrosine Kinase
13%
Immunotherapy
13%
Ovarian Cancer
13%
Gene Expression Profiling
12%
Tumor Cell
12%
Biological Marker
10%
Skin Cancer
10%
Diagnostic Accuracy
10%
Patient Care
10%
Drug Conjugate
10%
In Vitro
10%
Choriocarcinoma
7%
Endodermal Sinus Tumor
7%
Morphology
6%
Papillary Renal Cell Carcinomas
6%
Clear Cell Renal Cell Carcinoma
6%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
88%
Combination Therapy
82%
N (2 Hydroxypropyl)methacrylamide Copolymer
65%
Copolymer
61%
Prostate Cancer
61%
Neoplasm
46%
Gemcitabine
41%
Nanomedicine
41%
Ovary Cancer
34%
Drug Conjugate
32%
Cytotoxicity
30%
Cyclopamine
26%
Ovary Carcinoma
24%
Chemotherapy
23%
Docetaxel
22%
Acute Lung Injury
20%
Paclitaxel
20%
Disease
20%
Acute Myeloid Leukemia
20%
Prednisolone
20%
Glucocorticoid
20%
Melanoma
20%
Cytarabine
20%
Mammalian Target of Rapamycin Inhibitor
20%
Immunotherapy
13%
N-(2-Hydroxypropyl) Methacrylamide
10%
Mitogen Activated Protein Kinase Kinase Inhibitor
6%
Daunorubicin
6%
Hedgehog
6%
Recurrent Disease
6%
Skin Cancer
6%
Combination Drug
6%
Metastatic Melanoma
6%
Cell Marker
6%
Mortality Rate
6%
Tumor Growth
6%
Adult Respiratory Distress Syndrome
5%
Reactive Oxygen Metabolite
5%
